Recent Press Releases

TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare Pharmaceuticals

BRIDGEWATER, N.J. & FORT WORTH, Texas--Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. The...

PRA Health Sciences Expands Global Phase I Patient Strategy

RALEIGH, N.C. -- PRA Health Sciences (PRA) is enhancing its global Phase I patient strategy and increasing its clinical footprint with the expansion of its Early Development Services (EDS). These...

Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device...

X-Chem and Navitor Pharmaceuticals Enter into License Agreement on Novel Small Molecules Targeting mTORC1 Activation

WALTHAM & CAMBRIDGE, Mass.--X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery platform to the generation of novel small molecule therapeutics,...

Quintiles and Quest Diagnostics to Form Joint Venture to Provide Global Clinical Trials Laboratory Services

Combines the complementary strengths and scale of leading biopharmaceutical services and diagnostic information services providers New entity creates superior value proposition through the depth...

Recipharm and Adroit Science form collaboration to expand service offering

Recipharm AB and Adroit Science AB today announce the formation of a new strategic collaboration. Adroit Science AB will supportRecipharm's pharmaceutical development with high quality solid...

Ergomed Strengthens Presence In Asia To Meet Increasing Demand For Drug Development Services

London, UK: Ergomed plc, (LSE: ERGO or 'Ergomed') a profitable UK-based company, dedicated to the provision of specialised services to the pharmaceutical industry and the development of new...

BioClinica Opens Research Triangle Park Office

BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced the opening of a Research Triangle Park (RTP) office in North Carolina in response to a...

ICON and Carnegie Mellon University Collaborate to Evaluate Patient-centric Informed Consent Processes

DUBLIN--ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it is sponsoring...

CLINICAL INK MERGES WITH CENTROSHEALTH AND COMPLETES FINANCING LED BY MPM CAPITAL

--Enters strategic partnership to accelerate adoption of clinical trial technology platform-- BOSTON, PHILADELPHIA, WINSTON-SALEM – Clinical Ink, the pioneering provider of eSource solutions...

Society for Clinical Research Sites Expands Relationship with Acurian as First Site Engagement Partner

ELLICOTT CITY, Md. -- The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced an...

Catalent Announces New Organization To Speed New Products To Market

Somerset, N.J. — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today...

Second Genome and Evotec to collaborate in microbiome discovery and development

Hamburg, Germany: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Second Genome, Inc. today announced a collaboration in small molecule-based discovery and development...

WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer Immunotherapies

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device...

CROS NT Extends DATATRAK CONNECT® Partnership

CHAPEL HILL, N.C., March 9, 2015 -- CROS NT today announced that it is extending its partnership with DATATRAKas part of its life science technology portfolio. The partnership allows CROS NT to...

AMRI HIRES VP OF INTERNATIONAL SALES

ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) announced today that Michael Pettersson, fills the newly created position of VP of International Sales, effective immediately. He reports to Christopher Conway,...

ACRO Holds Initial Meeting of CRO Forum, Begins Two-Way Dialogue With TransCelerate

WASHINGTON--The Association of Clinical Research Organizations, whose members account for approximately two-thirds of contract clinical development services, held the inaugural meeting of the...

Altasciences and ITR Laboratories Form a Strategic Alliance

LAVAL, Québec--Altasciences, a provider of early phase clinical research services, and ITR Laboratories, a nonclinical services organization, announced today their strategic alliance offering...

Almac Discovery Initiates Phase 1 Study of ALM201 for the Treatment of Patients with Advanced Ovarian Cancer and other Solid Tumours

ALM201 represents the first clinical stage programme for Almac Discovery Craigavon, N.I., UK, – Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative...